Dr Patrick J TREACY

Cirujano Cosmético

Irlanda

Voted 'Irishman of the Year' Cork 2025
Lifetime Achievement Award China 2024
'Top Aesthetic Doctor in the World' 2019 (Las Vegas), Top Aesthetic Doctor in UK/Ireland (London) 2024

Winner AIDA Award (Abu Dhabi) 2022 for first doctor to use hyaluronidase in Aesthetic Medicine. President of the Royal Society of Medicine (London) Aesthetic Faculty 2019. In 2023, Tia Maria Lifetime Achievment Award for his outstanding vision, dedication, and commitment to research, philanthrophy and improving standards in Aesthetic Medicine through eduation and research

Winner – AIDA Trophy 'Outstanding Contributions to Aesthetic Medicine (Abu Dhabi) May 2022
Winner – MyFaceMyBody 'Top Global Medical Practitioner' 2019 (Las Vegas) November 2019…

Patrick J TREACY's cronograma

IMCAS China 2025

Julio 11, 2025

Regenerative medicine: Beyond borders

Secretomes and their application to aesthetic medicine

Julio 12, 2025

Economic Forum on Aesthetic market

Chair

Julio 13, 2025

Cosmeceuticals, nutraceuticals, & Chinese medicine

Cosmeceuticals: How active compounds affect your skin

Injectables: How to avoid complications

Chair
Dermal filler-related blindness: Mechanisms, prevention, and modern management

Patrick J TREACY's presentaciones (16)

Patrick J TREACY's informes (2)

Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads.

Sep, 2006

Orbital fat tissue, while important in protecting the eye, can protrude during aging, making a patient look 'tired'. Surgical correction, although traditionally the treatment of choice, can lead to scarring. Phosphatidylcholine (PPT) has been shown to reduce the size of these fat pads after direct injection. The compound, licensed in Europe for intravenous treatment of fat embolism, has recently gained interest for reducing localized fat by subcutaneous injection. However, there is a dearth of clinical data relating to efficacy and side effects. leer más

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology

Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs.

Jun, 2006

To evaluate the efficacy, overall esthetic effect, and safety of a new permanent, polyalkylimide dermal filler in HIV-infected patients with severe facial lipodystrophy. leer más

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]